“…Immunostaining of oocytes with the anti-pS659-BubR1 antibody, which detects Cdk1-dependent phosphorylation of the KARD domain (Elowe et al, 2010;Huang et al, 2008;Kruse et al, 2013), revealed a progressive increase in the amount of phosphorylated BubR1 at the KTs throughout prometaphase and metaphase I ( Figure 4C), whereas the amount of total BubR1 at KTs showed a progressive decrease ( Figure S4A). Moreover, the amount of pT669-BubR1 in the KARD domain, which is mediated by Plk1 (Solc et al, 2015;Suijkerbuijk et al, 2012), also showed a progressive increase ( Figure S4B). Consistent with these results, the overexpression of cyclin B1, which increases Cdk1 activity (Davydenko et al, 2013), increased the amount of pS659-BubR1 ( Figure S4C) and the amount of PP2A-B56 localized to the KTs ( Figure S4D).…”